Scholay

学术搜索 · AI 审稿 · LaTeX 协作

G. Curigliano

发表论文 869 篇 · 总被引 41720 次 · h-index 92

代表论文

  • Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial (2025 · Nature Medicine · 被引 104)
  • Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial (2024 · ESMO Open · 被引 72)
  • Innovative payloads for ADCs in cancer treatment: moving beyond the selective delivery of chemotherapy (2025 · Therapeutic Advances in Medical Oncology · 被引 56)
  • Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT (2024 · Journal of Clinical Oncology · 被引 41)
  • Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact. (2025 · European Journal of Cancer · 被引 28)
  • TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer (2025 · Therapeutic Advances in Medical Oncology · 被引 26)